EP Patent

EP1318787A2 — Pharmaceutical suspension compositions lacking a polymeric suspending agent

Assigned to Alcon Inc · Expires 2003-06-18 · 23y expired

What this patent protects

Stable aqueous pharmaceutical suspension compositions containing lecithin as a stabilizing additive and lacking a polymeric suspending agent are disclosed.

USPTO Abstract

Stable aqueous pharmaceutical suspension compositions containing lecithin as a stabilizing additive and lacking a polymeric suspending agent are disclosed.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1318787A2
Jurisdiction: EP
Classification: —
Expires: 2003-06-18
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.